90%Confidence
0Views
FDASource
2026-03-11Date
Summary
Recall of Amantadine HCl capsules by AvKARE due to failed dissolution specifications suggests potential bioavailability issues, which could affect therapeutic efficacy. This may temporarily disrupt supply for this generic neurological/antiviral medication.
Actionable: Check alternative sources for Amantadine HCl to ensure patient access and monitor AvKARE for further quality control announcements.
AI Confidence: 90%
Data Points
firmAvKARE
classificationClass II
statusOngoing
distributionNationwide in the USA.
productAmantadine HCl, Capsules, UPS, 100 mg, 50 Capsules (5 x 10) unit dose, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, www.avkare.com, NDC 50268
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now